Chief Supply Chain Officer Hibbert Paul converted options into 9,922 shares and covered exercise/tax liability with 4,600 shares, increasing direct ownership by 12% to 48,565 units (SEC Form 4)
$EPC
Package Goods/Cosmetics
Consumer Discretionary
| FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
| Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | |||||||||||||||||
| Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. | |||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
EDGEWELL PERSONAL CARE Co [ EPC ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
|
3. Date of Earliest Transaction
(Month/Day/Year) 11/06/2025 | ||||||||||||||||||||||||||
|
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
| Code | V | Amount | (A) or (D) | Price | ||||||
| Common Stock | 11/13/2025 | M(1) | 5,773 | A | $0 | 49,015.693 | D | |||
| Common Stock | 11/13/2025 | F | 2,676(2) | D | $18.39 | 46,399.693 | D | |||
| Common Stock | 11/13/2025 | M(3) | 4,149 | A | $0 | 50,488.693 | D | |||
| Common Stock | 11/13/2025 | F | 1,924(2) | D | $18.39 | 48,564.693 | D | |||
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Performance Stock Equivalents 11-11-2022 | $0 | 11/13/2025 | M | 5,773 | 11/13/2025(1) | (1) | Common Stock | 5,773 | $0 | 0 | D | ||||
| Performance Stock Equivalents 11-8-2024 | $0 | 11/06/2025 | A | 4,149 | 11/13/2025(3) | (3) | Common Stock | 4,149 | $0 | 4,149 | D | ||||
| Performance Stock Equialents 11-8-2024 | $0 | 11/13/2025 | M | 4,149 | 11/13/2025(3) | (3) | Common Stock | 4,149 | $0 | 0 | D | ||||
| Restricted Stock Equivalents 11-14-2025 | $0 | 11/14/2025 | A | 15,445 | 11/14/2026(4) | (4) | Common Stock | 15,445 | $0 | 15,445 | D | ||||
| Explanation of Responses: |
| 1. Each Performance Stock Equivalent ("PSE") is convertible into one share of common stock of Edgewell Personal Care Company ("EPC"). The performance conditions with respect to 5,773 PSEs were satisfied and vested into EPC common stock on November 13, 2025. The remaining 10,580 PSEs did not satisfy the necessary performance conditions and were canceled on the same date. |
| 2. Reflects shares withheld as payment of a tax liability upon vesting of PSEs. |
| 3. Reflects an award of PSEs for which the performance conditions were satisfied on November 6, 2025 and remaining time vesting conditions were satisfied on November 13, 2025. Each PSE is convertible into shares of EPC common stock. |
| 4. Each Restricted Stock Equivalent ("RSE") is convertible into one share of EPC common stock. The award of RSEs shall vest as to one-third of the original grant of 15,445 RSEs on each of the first three anniversaries of the grant date. |
| /s/ Paul Hibbert | 11/18/2025 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||